C535-0912 Screening compound: 4-{1-[3-(3,4-dimethoxyphenyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-yl]piperidine-4-carbonyl}morpholine

C535-0912 Screening compound: 4-{1-[3-(3,4-dimethoxyphenyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-yl]piperidine-4-carbonyl}morpholine
C535-0912 Screening compound: 4-{1-[3-(3,4-dimethoxyphenyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-yl]piperidine-4-carbonyl}morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound C535-0912
4-{1-[3-(3,4-dimethoxyphenyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-yl]piperidine-4-carbonyl}morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C535-0912

Molecular Formula

C26H33N5O4 (C26 H33 N5 O4)

Compound Name

4-{1-[3-(3,4-dimethoxyphenyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-yl]piperidine-4-carbonyl}morpholine

IUPAC name

4-{1-[3-(34-dimethoxyphenyl)-25-dimethylpyrazolo[15-a]pyrimidin-7-yl]piperidine-4-carbonyl}morpholine

SMILES

Cc1nn2c(N(CC3)CCC3C(N3CCOCC3)=O)cc(C)nc2c1-c(cc1)cc(OC)c1OC

InChI

InChI=1S/C26H33N5O4/c1-17-15-23(29-9-7-19(8-10-29)26(32)30-11-13-35-14-12-30)31-25(27-17)24(18(2)28-31)20-5-6-21(33-3)22(16-20)34-4/h5-6,15-16,19H,7-14H2,1-4H3

InChI Key

XAIJBRVZORFUCD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14768620

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

479.58

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.341

Distribution Coefficient, logD

0.765

Water Solubility, LogSw

-2.68

Polar Surface Area

62.675

Acid Dissociation Constant (pKa)

23.23

Base Dissociation Constant (pKb)

8.96

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

50.00

C535-0912 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Akt-Targeted Library (14764 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Kinases
  • Phosphatases

References: we are preparing a list of scientific research reports with C535-0912 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C535-0912?
Check Price and Availability of C535-0912, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C535-0912 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C535-0912
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C535-0912
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C535-0912 available by request